From paper to electronic data

Size: px
Start display at page:

Download "From paper to electronic data"

Transcription

1 From paper to electronic data Bioindustrypark, October 10, 2013 Dr Alessandra Grande Ivrea GxP Test Facility QA Manager, Head Global BMT QA Research & Development Quality Assurance MerckSerono RBM

2 Outline Kind of data Requisites Applications Conclusions

3 Outline Kind of data Requisites Applications Conclusions

4 Guideline evolution OECD Monogr aph No. 10; The Applicat ion of the Principl es of GLP to CS 1995 EPA GALPs Good Automat ed Laborato ry Practice CFR 11, Electronic Records; Electronic Signatures final rule, 1997 FDA Guidance for Industry, Part 11 Scope and Applicatio n, AGIT, Guidelines For The Acquisition And Processing Of Electronic Raw Data In a GLP Environment, ISPE GAMP Good Practice Guide, Part 11 Compliant Electronic Records and Signatures FDA Guidance for Industry; CS used in Clinical Trials Updated May 2007 Red Apple II CS in Nonclinical Safety Assessment: Current Concepts in Validation and Compliance 2007 Peach EU CS in GMP Clinical Annex Research: 11 CS, Current 2011 Quality and Data Integrity Concepts 2008 ISPE GAMP Good Practice Guide: Risk-Based Approach to GxP Compliant Laboratory CS, Paper homogeneous Paper and electronic system hybrid Electronic homogeneous

5 Paper vs e-data At the beginning of 2000, after the FDA 21 Part 11 publication moving from paper to electronic seemed to have some pro and some cons: Lack of - confidence - CS knowledge - guideline interpretation Trendy Costs Space

6 Paper vs e-data Paper Methodologies well established and stable Electronic Computer technologies & languages change frequently Information can be read without any tools e-management requires the use of computer languages & technology Paper records are understandable without the use of additional records. e-record is not self contained & requires other records to understand its meaning

7 Data definition in regulated environment GLP OECD Raw data means all original test facility records and documentation, or verified copies thereof, which are the result of the original observations and activities in a study. Raw data also may include, for example, photographs, microfilm or microfiche copies, computer readable media, dictated observations, recorded data from automated instruments, or any other data storage medium that has been recognised as capable of providing secure storage of information.. GCP ICH Source Data: all information in original records and certified copies of original records of clinical findings, observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial EU GMP Chapter 4 Documentation may exist in a variety of forms, including paperbased, electronic or photographic media. The term 'written' means recorded, or documented on media from which data may be rendered in a human readable form. Records include the raw data which is used to generate other records. For electronic records regulated users should define which data are to be used as raw data. At least, all data on which quality decisions are based should be defined as raw data

8 Raw Data/Source Data - Meta Data Raw data: original observations/activities recorded contemporaneously Raw/source data collected on a computer system can be: Electronic records Computer generated printouts Other media Meta Data: information held in the computer system which translates and/or supports the data (e.g Instrument settings). - Must be maintained for as long as the data is required - Specific to the software application - Integrity of data requires integrity of metadata

9 Data in the e-environment In computer science, data is anything in a form suitable for use with a computer. If a program is a set of instructions that detail a task for the computer to perform; data is everything that is not program code. Data is what the users and regulators are interested in. Binary files (which are not human-readable) are sometimes called "data" as distinguished from human-readable text

10 e-data systems in drug development Pre-clinical Laboratory Information Management Systems, Clinical pathology Phase I Safety and tolerance CRF data management, EDC (Electronic Data Capture) Phase II - Safety and Efficacy Phase III Study enrolment, Drug supply, Data capture, Clinical records Statistics, Regulatory Submissions, Health Economics Pharmacovigilance Adverse Events Reporting Documentation management Change control (TW), Procedures (EDMS) E&V/Maintenance SAP, Building Management System

11 Outline Kind of data Requisites Applications Conclusions

12 Data requisites Independently of the support, the data must be ALCOA Attributable Legible Contemporaneous Original Accurate

13 E-data requisite In particular e-data must guarantee data integrity. Data without integrity is not worth keeping Must for GxP compliance Business needs Integrity from collection to submission From cradle to grave

14 Data integrity Data integrity depends on these attributes Reliable Available Accurate Attributable Accountable Data Integrity Legible Contemp Original Secure

15 Data Must be Accurate and Reliable In order to ensure reliable data: Computerised systems must be validated to current standards Validation status must be maintained - change control - periodic review IT infrastructure must be controlled and qualified through - maintenance - IT continuity - disaster recovery

16 Data Must be Accountable/Attributable Data must be: Authenticated I did it Attributable He did it Who recorded the original data and when? Who s worked on derived data and when? Who is responsible for the data?

17 Data Must be Accountable/Attributable Data Audit Trail Proof of data authenticity Allows study/trial reconstruction May also contain details of computer system configuration Reports changes made, who made them, when and their reason (not obscuring original data) Reports date and time of data (controlled by the Server) Users must not be able to change audit trail information

18 Data Must be Available Data must be available for all the data life. - after their recording and before archiving - after archiving - after system retirement

19 Data Must be Available Back-up and Recovery Agreed frequency Suitable media Secure storage of back-ups Routine testing to verify accuracy Procedure for handling failures Documentary evidence Backup is NOT archival!

20 Data Must be Available Data Archiving Assurance that archiving information in an electronic medium will be usable (readable and extractable) in many years Hardware, software and algorithms evolve is data integrity maintained during technology change? GLP principles require study material to be archived after the final report signature. This applies also to electronic data. For other GxP principles the archival requirement is not statute even if they do archive

21 Data Must be Available System Retirement Ensure e-data continue to be available and are humanly readable Consideration of Regulatory retention period Business needs IT issues Practicalities. Solutions to keep data available Migration of e-data to a new system Transform data into common format Systems are not available forever, however data may need to be!

22 Data Must be Secure There are 2 kinds of security Physical Logical

23 Data Must be Secure Physical security Records: restricted access to records and materials People: proof of authentication, e.g. staff ID badges Area: restricted access to buildings, laboratories, server

24 Data Must be Secure Logical security Data entry Passwords Biometrics: User ID authenticated by unique body part (e.g. retinal scans, finger prints) 21 CFR Part 11. Concept not usually implemented in GxP environment Different access rights (Who manages and maintains access controls) Infrastructure Control receipt of transmission through Firewall Monitor network for viruses and isolation of detected viruses Update of antivirus & firewall software.

25 QA involvement in Computerised Systems Computerised systems are no different from any other system/process QA may encounter (but require special considerations) QA are required to indicate the extent of their involvement in computer activities. GLP regulations mention auditing of computerised systems OECD Monograph No 10 The Application of the Principles of GLP to Computerised Systems specifically indicates: QA responsibilities must be defined by management and described in written policies and procedures QA personnel are required to audit and monitor the compliance of computerised systems. GCP and GMP do not mention any QA activities specific to computerised systems

26 Outline Kind of data Requisites Applications Conclusions

27 electronic Common Technical Document (ectd) The ectd is an interface for industry-to-agency transfer of regulatory information and documents in a regulatory submission The specification of the ectd is based up on the content defined in the International Conference on Harmonisation (ICH) M4 expert working group (EWG)

28 Standard for Exchange of Nonclinical Data SEND (Standard for Exchange of Nonclinical Data), is an implementation of the Standard Data Tabulation Model (SDTM) for nonclinical studies. It specifies the format for reporting non-clinical study to the FDA. Past/now Report and tables Now/Future Report and tables SEND files

29 EudraCT EUDRACT is the European Clinical Trials Database of all clinical trials of investigational medicinal products with at least one site in the EU (since 1 May 2004). This database has been established to: Facilitate communication between competent authorities Link with other databases such as EudraVigilance and EU Clinical Trials Register. Facilitate communication on trials between authorities Improve oversight of medicinal product development Enhance protection of clinical trail subjects Legal basis is Clinical Trials Directive 2001/20/EC

30 Outline Kind of data Requisites Applications Conclusions

31 Conclusion To move to e-data is no longer a choice for various reasons: Business Regulatory

32 Business Requirements Intellectual property issues, establish ownership Most information generated today is in electronic format Logistics: 250,000 pages can be stored on a single DVD ROM Templates: Data manipulation requires standard formats for efficiency Electronic data capture obviates the need for paper (e.g. Patients can enter their own results using a PDA) Statistical analyses can be validated, automated calculation eliminates the human factor

33 Compliance/regulatory Requirements Raw data definition: for hybrid systems, it has to be demonstrated that both the signed paper printout and the electronic records that generated it are defined as raw data / electronic records and they are maintained and protected throughout the record retention period. Process more transparent to inspectors Approval: Regulatory authority queries can be answered immediately

34 Paper vs e-data Lack of - confidence - CS knowledge - guideline interpretation Trendy Costs Space

35 Paper vs e-data Costs of validation maintenance Confidence CS knowledge guidelines interpretation Space Susteinability Compliance

36 Some open issues Data availability: how can you demonstrate that your data will be readable in 20 years data reliability in hybrid systems: how do you keep electronic and paper records synchronised so that they say the same thing? data reliability: how to manage manual entry (retrospectively) of critical data; checked by a second person or a validated process using the computer itself?

37 Thanks for your attention

Clinical database/ecrf validation: effective processes and procedures

Clinical database/ecrf validation: effective processes and procedures TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS

GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS European Medicines Agency London, 17 October 2007 Doc. Ref. EMEA/505620/2007 GCP INSPECTORS WORKING GROUP REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS

More information

GCP - Records Managers Association

GCP - Records Managers Association GCP - Records Managers Association Guidance on the Scanning and Destruction of Paper Records 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 The introduction

More information

Computerised Systems. Seeing the Wood from the Trees

Computerised Systems. Seeing the Wood from the Trees Computerised Systems Seeing the Wood from the Trees Scope WHAT IS A COMPUTERISED SYSTEM? WHY DO WE NEED VALIDATED SYSTEMS? WHAT NEEDS VALIDATING? HOW DO WE PERFORM CSV? WHO DOES WHAT? IT S VALIDATED -

More information

GOOD LABORATORY PRACTICE (GLP)

GOOD LABORATORY PRACTICE (GLP) AGIT Guidelines for the Archiving of Electronic Raw Data 1 / 13 GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE ARCHIVING OF ELECTRONIC RAW DATA IN A GLP ENVIRONMENT Working Group on Information Technology

More information

OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT

OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT GENERAL DISTRIBUTION OCDE/GD(95)115 OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT THE APPLICATION OF THE PRINCIPLES OF GLP TO COMPUTERISED

More information

Testing Automated Manufacturing Processes

Testing Automated Manufacturing Processes Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls

More information

Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS

Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS U.S. Department of Health and Human Services Food and Drug Administration Center for Biologic Evaluation and Research (CBER) Center for

More information

A Guide to Archiving of Electronic Records

A Guide to Archiving of Electronic Records A Guide to Archiving of Electronic Records 18th February 2014 A Guide to Archiving of Electronic Records The Scientific Archivists Group (SAG) formed a Working Party to develop guidance to assist in the

More information

Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials

Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials 09 June 2010 EMA/INS/GCP/454280/2010 GCP Inspectors Working Group (GCP IWG) Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical

More information

Supplement to the Guidance for Electronic Data Capture in Clinical Trials

Supplement to the Guidance for Electronic Data Capture in Clinical Trials Supplement to the Guidance for Electronic Data Capture in Clinical Trials January 10, 2012 Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Note: The original language of this

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Electronic Source Data in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for

More information

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (08) 69 3R Full document title and reference Document type VALIDATION OF COMPUTERISED SYSTEMS Legislative basis - CORE DOCUMENT

More information

Validation Consultant

Validation Consultant Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de

More information

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment IVTGXP_july06.qxd 6/28/06 1:09 PM Page 36 Computerized System Audits In A GCP Pharmaceutical Laboratory Environment By Maintaining data integrity for both clinical laboratory processes and patient data

More information

Stockholm, September 22 nd 2015. Rules, Regulations and Requirements

Stockholm, September 22 nd 2015. Rules, Regulations and Requirements Stockholm, September 22 nd 2015 Rules, Regulations and Requirements Presentation Objectives To describe the regulatory environment applicable to the use of electronic data in clinical trials To give a

More information

Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11)

Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11) Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11) The title 21 code of federal regulations part 11 deals with an institutions

More information

Manual 074 Electronic Records and Electronic Signatures 1. Purpose

Manual 074 Electronic Records and Electronic Signatures 1. Purpose 1. Purpose The purpose of this document is to provide an interpretation of FDA 21 CFR Part 11, Electronic Records; Electronic Signatures (ER/ES) and to provide guidance for acceptable practices in the

More information

Managing & Validating Research Data

Managing & Validating Research Data Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical

More information

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014 Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing

More information

How To Manage An Electronic Standard Operating Procedure

How To Manage An Electronic Standard Operating Procedure AGIT Management of electronic SOPs 1 / 14 GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT Working Group Information

More information

OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD

OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD 1. The following draft Advisory Document will replace the 1995 OECD GLP Consensus Document number 10

More information

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality

More information

Clinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS

Clinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS Clinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS Training Course in Sexual and Reproductive Health Research Geneva 2013 OUTLINE Overview of Clinical Data

More information

Considerations for Management of Laboratory Data

Considerations for Management of Laboratory Data Considerations for Management of Laboratory Data 2003 Scientific Computing & Instrumentation LIMS Guide, November 2003 Michael H Elliott Drowning in a sea of data? Nervous about 21 CFR Part 11? Worried

More information

Guidance for Industry Computerized Systems Used in Clinical Investigations

Guidance for Industry Computerized Systems Used in Clinical Investigations Guidance for Industry Computerized Systems Used in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of the Commissioner (OC) May 2007 Guidance

More information

Nova Southeastern University Standard Operating Procedure for GCP. Title: Electronic Source Documents for Clinical Research Study Version # 1

Nova Southeastern University Standard Operating Procedure for GCP. Title: Electronic Source Documents for Clinical Research Study Version # 1 Nova Southeastern University Standard Operating Procedure for GCP Title: Electronic Source Documents for Clinical Research Study Version # 1 SOP Number: OCR-RDM-006 Effective Date: August 2013 Page 1 of

More information

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing

More information

Auditing Chromatographic Electronic Data. Jennifer Bravo, M.S. QA Manager Agilux Laboratories

Auditing Chromatographic Electronic Data. Jennifer Bravo, M.S. QA Manager Agilux Laboratories Auditing Chromatographic Electronic Data Jennifer Bravo, M.S. QA Manager Agilux Laboratories Outline Raw data paper or electronic record? Controls for electronic data Auditing electronic records Warning

More information

Services Providers. Ivan Soto

Services Providers. Ivan Soto SOP s for Managing Application Services Providers Ivan Soto Learning Objectives At the end of this session we will have covered: Types of Managed Services Outsourcing process Quality expectations for Managed

More information

Z.A.S. Archive- and informationsmanagement

Z.A.S. Archive- and informationsmanagement Z.A.S. Archive- and informationsmanagement Presentation at SAG Scientific Archivists Group Spring Conference in Basel 11 June 2010 Electronic Archiving in a GXP-regulated environment Author: Bernd Mohnsame

More information

Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA

Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and

More information

Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development

Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development Unclassified ENV/JM/MONO(2016)13 ENV/JM/MONO(2016)13 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 22-Apr-2016 English

More information

What is the correct title of this publication? What is the current status of understanding and implementation?

What is the correct title of this publication? What is the current status of understanding and implementation? GMP Rules and Guidelines in 2013 for Computer System Validation / Computerises Systems / Electronic Records and Signatures/ IT Infrastructure and Application Compliance: What is the correct title of this

More information

Assuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise

Assuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise Assuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise 2013 Waters Corporation 1 Agenda Electronic Record regulations, Compliance Policy Guides and Warning

More information

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process

More information

GLP Records Storage and Retrieval

GLP Records Storage and Retrieval GLP Records Storage and Retrieval Cindy Green BBS UNITED, ALEX HAYDEN/GETTY IMAGES GLP Topics addresses topics associated with good laboratory practice requirements. We intend this column to be a useful

More information

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,

More information

Using SharePoint 2013 for Managing Regulated Content in the Life Sciences. Presented by Paul Fenton President and CEO, Montrium

Using SharePoint 2013 for Managing Regulated Content in the Life Sciences. Presented by Paul Fenton President and CEO, Montrium Using SharePoint 2013 for Managing Regulated Content in the Life Sciences Presented by Paul Fenton President and CEO, Montrium Overview Informative Webinar that aims to provide an overview of how SharePoint

More information

Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS

Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS Training Course in Sexual and Reproductive Health Research Geneva 2012 OUTLINE Clinical Data Management CDM

More information

What is necessary to provide good clinical data for a clinical trial?

What is necessary to provide good clinical data for a clinical trial? What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction

More information

PKI Adoption Case Study (for the OASIS PKIA TC) ClinPhone Complies with FDA Regulations Using PKIbased Digital Signatures

PKI Adoption Case Study (for the OASIS PKIA TC) ClinPhone Complies with FDA Regulations Using PKIbased Digital Signatures PKI Adoption Case Study (for the OASIS PKIA TC) ClinPhone Complies with FDA Regulations Using PKIbased Digital Signatures PKI Project Title Digital Signatures for ClinPhone Organisation concerned ClinPhone

More information

Declaration of Conformity 21 CFR Part 11 SIMATIC WinCC flexible 2007

Declaration of Conformity 21 CFR Part 11 SIMATIC WinCC flexible 2007 Declaration of Conformity 21 CFR Part 11 SIMATIC WinCC flexible 2007 SIEMENS AG Industry Sector Industry Automation D-76181 Karlsruhe, Federal Republic of Germany E-mail: pharma.aud@siemens.com Fax: +49

More information

Sponsor Site Questionnaire FAQs Regarding Maestro Care

Sponsor Site Questionnaire FAQs Regarding Maestro Care Sponsor Site Questionnaire FAQs Regarding Maestro Care Data Security and Validation 1. Are the electronic source documents or computer systems specific to the site and/or developed by the site? a. Developed

More information

DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS

DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS Reference Number: UHB 139 Version Number: 2 Date of Next Review: 14 Apr 2018 Previous Trust/LHB Reference Number: N/A DATA MANAGEMENT IN CLINICAL TRIALS: GUIDELINES FOR RESEARCHERS Introduction and Aim

More information

TIBCO Spotfire and S+ Product Family

TIBCO Spotfire and S+ Product Family TIBCO Spotfire and S+ Product Family Compliance with 21 CFR Part 11, GxP and Related Software Validation Issues The Code of Federal Regulations Title 21 Part 11 is a significant regulatory requirement

More information

DAIDS Appendix 2 No.: DWD-POL-DM-01.00A2. Data Management Requirements for Central Data Management Facilities

DAIDS Appendix 2 No.: DWD-POL-DM-01.00A2. Data Management Requirements for Central Data Management Facilities DAIDS Appendix 2 No.: DWD-POL-DM-01.00A2 Data Management Requirements for Central Data Management Facilities The following clinical trial data management requirements must be met in order to ensure the

More information

Oracle WebCenter Content

Oracle WebCenter Content Oracle WebCenter Content 21 CFR Part 11 Certification Kim Hutchings US Data Management Phone: 888-231-0816 Email: khutchings@usdatamanagement.com Introduction In May 2011, US Data Management (USDM) was

More information

Good Documentation Practices

Good Documentation Practices Good Documentation Practices Clinical Research Operations & Regulatory Support Ann Glasse, RN, BSN, MBA Director, Regulatory Support Author: Johanna Stamates, RN, MA, CCRC, CHRC Objectives Recognize the

More information

Risk-Based Approach to 21 CFR Part 11

Risk-Based Approach to 21 CFR Part 11 3109 W. Dr. Martin Luther King, Jr. Blvd., Suite 250 Tampa, FL 33607 USA Tel: 813/960-2105 Fax: 813/264-2816 www.ispe.org Risk-Based Approach to 21 CFR Part 11 The 21 CFR Part 11 regulation is a comprehensive

More information

STANDARD OPERATING PROCEDURE FOR DATA RETENTION

STANDARD OPERATING PROCEDURE FOR DATA RETENTION STANDARD OPERATING PROCEDURE FOR DATA RETENTION SOP Number: GCP DM 505.02 Version Number & Date: 2 nd Version; 25 Apr 2013 Superseded Version Number & Date (if applicable): 1 st Version; 17 June 2010 Effective

More information

Implement best practices by using FileMaker Pro 7 as the backbone of your 21 CFR 11 compliant system.

Implement best practices by using FileMaker Pro 7 as the backbone of your 21 CFR 11 compliant system. 21 CRF 11 Electronic Records and Signatures Implement best practices by using FileMaker Pro 7 as the backbone of your 21 CFR 11 compliant system. By Todd Duell What does Title 21 of the Code of Federal

More information

Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries

Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries White Paper No 01 I December 2010 Implementation of 21 CFR Part 11 in the epmotion Software Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device

More information

ScreenMaster RVG200 Paperless recorder FDA-approved record keeping. Measurement made easy

ScreenMaster RVG200 Paperless recorder FDA-approved record keeping. Measurement made easy Information INF13/147 EN ScreenMaster RVG200 Paperless recorder FDA-approved record keeping Measurement made easy Guidance on the use of the RVG200 paperless recorder for electronic record keeping in FDA-approved

More information

Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements

Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements / WHITE PAPER Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements The 21 CFR Part 11 rule states that the FDA view is that the risks of falsification, misinterpretation,

More information

Final Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture

Final Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture Final Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture CDER Leonard Sacks, Office of Medical Policy Ron Fitzmartin, Office of Strategic Programs Jonathan Helfgott,

More information

Guidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Electronic Copies of Electronic Records

Guidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Electronic Copies of Electronic Records Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures Electronic Copies of Electronic Records Draft Guidance This guidance document is being distributed for comment purposes only.

More information

CONTENTS. List of Tables List of Figures

CONTENTS. List of Tables List of Figures Prelims 13/3/06 9:11 pm Page iii CONTENTS List of Tables List of Figures ix xi 1 Introduction 1 1.1 The Need for Guidance on ERP System Validation 1 1.2 The Need to Validate ERP Systems 3 1.3 The ERP Implementation

More information

Compliance Response Edition 07/2009. SIMATIC WinCC V7.0 Compliance Response Electronic Records / Electronic Signatures. simatic wincc DOKUMENTATION

Compliance Response Edition 07/2009. SIMATIC WinCC V7.0 Compliance Response Electronic Records / Electronic Signatures. simatic wincc DOKUMENTATION Compliance Response Edition 07/2009 SIMATIC WinCC V7.0 Compliance Response Electronic Records / Electronic Signatures simatic wincc DOKUMENTATION Compliance Response Electronic Records / Electronic Signatures

More information

Data Governance Planning PDA 12 May 2015

Data Governance Planning PDA 12 May 2015 Data Governance Planning PDA 12 May 2015 1 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2 Overview of Data Integrity 3 Data Information derived

More information

IT General Controls Domain COBIT Domain Control Objective Control Activity Test Plan Test of Controls Results

IT General Controls Domain COBIT Domain Control Objective Control Activity Test Plan Test of Controls Results Acquire or develop application systems software Controls provide reasonable assurance that application and system software is acquired or developed that effectively supports financial reporting requirements.

More information

Data Management Unit Research Institute for Health Sciences, Chiang Mai University

Data Management Unit Research Institute for Health Sciences, Chiang Mai University Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data

More information

Use of Electronic Health Record Data in Clinical Investigations

Use of Electronic Health Record Data in Clinical Investigations Use of Electronic Health Record Data in Clinical Investigations Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

Life Cycle of Records

Life Cycle of Records Discard Create Inactive Life Cycle of Records Current Retain Use Semi-current Records Management Policy April 2014 Document title Records Management Policy April 2014 Document author and department Responsible

More information

Qualification Guideline

Qualification Guideline Qualification Guideline June 2013 Disclaimer: This document is meant as a reference to Life Science companies in regards to the Microsoft O365 platform. Montrium does not warrant that the use of the recommendations

More information

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International

Data Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,

More information

21 CFR Part 11 Checklist

21 CFR Part 11 Checklist 21 CFR Part 11 Checklist GUIDE NOTOCORD - 113 Chemin de Ronde - 78290 Croissy-sur-Seine www.notocord.com my.notocord.com support@notocord.com +33 (0)1 34 80 00 00 1. Preliminary information 1.1. Purpose

More information

THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE

THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE The objective of this article is to discuss the 21 CFR Part 11 compliance utility of the Waters NuGenesis Scientific Data Management System

More information

Full Compliance Contents

Full Compliance Contents Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex

More information

Adoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012

Adoption by GCP Inspectors Working Group for consultation 14 June 2011. End of consultation (deadline for comments) 15 February 2012 10 December 2013 EMA/INS/GCP/600788/2011 Compliance and Inspection Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials, with particular

More information

Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application

Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application Guidance for Industry Part 11, Electronic Records; Electronic Signatures Scope and Application U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research

More information

Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples

Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples 28 February 2012 EMA/INS/GCP/532137/2010 GCP Inspectors Working Group Reflection paper for laboratories that perform the analysis or evaluation of clinical trial Draft agreed by GCP Inspectors Working

More information

GLP Compliance in Digital Pathology. Curtis Adams Ph.D. Sr. Product Manager Life Sciences curtis@aperio.com

GLP Compliance in Digital Pathology. Curtis Adams Ph.D. Sr. Product Manager Life Sciences curtis@aperio.com GLP Compliance in Digital Pathology Curtis Adams Ph.D. Sr. Product Manager Life Sciences curtis@aperio.com June 30, 2011 Agenda General Considerations General Laboratory Practices history agencies guidelines

More information

Compliance Response SIMATIC SIMATIC PCS 7 V8.1. Electronic Records / Electronic Signatures (ERES) Edition 03/2015. Answers for industry.

Compliance Response SIMATIC SIMATIC PCS 7 V8.1. Electronic Records / Electronic Signatures (ERES) Edition 03/2015. Answers for industry. SIMATIC SIMATIC PCS 7 V8.1 Electronic Records / Electronic Signatures (ERES) Compliance Response Edition 03/2015 Answers for industry. Compliance Response Electronic Records / Electronic Signatures (ERES)

More information

How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program

How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation

More information

The use of computer systems

The use of computer systems Technology Update Computer Systems Validation, Part 1 Software Purchase and GCP Compliance Teri Stokes Teri Stokes, PhD, is senior consultant and director of GXP International, 131 Sudbury Road, Concord,

More information

Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities

Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities September 2, 2003 Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities Purpose This document provides a summary of the requirements relating to use of computer-based systems in activities

More information

Empower TM 2 Software

Empower TM 2 Software Empower TM 2 Software 21 CFR PART 11 COMPLIANCE ASSESSMENT Revision A, December, 2005 1 of 14 Waters Corporation Note: Information presented in this document assumes that the appropriate Empower 2 System

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Electronic Source Data in Clinical Investigations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft

More information

21 CFR Part 11 Electronic Records & Signatures

21 CFR Part 11 Electronic Records & Signatures Gap Analysis - Checklist 21 CFR Part 11 Electronic Records & Signatures his document is a proposal and starting point only. he type and extent of documentation depends on the process environment. he proposed

More information

Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic) for management, audit and inspection of clinical trials

Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic) for management, audit and inspection of clinical trials 1 2 3 15 June 2015 EMA/INS/GCP/636736/2012 Good Clinical Practice Inspectors Working Group (GCP IWG) 4 5 6 7 Reflection paper on GCP compliance in relation to trial master files (paper and/or electronic)

More information

21 CFR Part 11 Compliance Using STATISTICA

21 CFR Part 11 Compliance Using STATISTICA 21 CFR Part 11 Compliance Using STATISTICA Last Updated: April 2003 This document was updated to reflect the FDA s latest guidance (released February, 2003) and the withdrawal of previous guidance.! STATSOFT

More information

FDA Regulation of Electronic Source Data in Clinical Investigations

FDA Regulation of Electronic Source Data in Clinical Investigations FDA Regulation of Electronic Source Data in Clinical Investigations Q1 Productions Second Annual Innovations in Clinical Data Management Conference, Arlington, VA Mahnu Davar Presented on Oct. 28, 2014

More information

REGULATIONS COMPLIANCE ASSESSMENT

REGULATIONS COMPLIANCE ASSESSMENT ALIX is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation. REGULATIONS COMPLIANCE ASSESSMENT BUSINESS

More information

Regulated Applications in the Cloud

Regulated Applications in the Cloud Keith Williams CEO Regulated Applications in the Cloud Aspects of Security and Validation Statement on the Cloud and Pharma s added Complexity Clouds already make sense for many small and mediumsize businesses,

More information

Validating Enterprise Systems: A Practical Guide

Validating Enterprise Systems: A Practical Guide Table of Contents Validating Enterprise Systems: A Practical Guide Foreword 1 Introduction The Need for Guidance on Compliant Enterprise Systems What is an Enterprise System The Need to Validate Enterprise

More information

Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials

Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials Vanessa Grant and Tim Stiles VERSION 2 Published by

More information

Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence

Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Heather Longden Senior Marketing Manager, Informatics Regulatory Compliance 2015

More information

LabChip GX/GXII with LabChip GxP Software

LabChip GX/GXII with LabChip GxP Software Regulatory Compliance LabChip GX/GXII with LabChip GxP Software Supporting Regulatory Compliance Caliper LabChip GX/GXII suite of instruments provides automated electrophoresis to analyze quality, size,

More information

21 CFR Part 11 White Paper

21 CFR Part 11 White Paper 21 CFR Part 11 White Paper Version V8.00 SR1 ProLeiT AG Einsteinstrasse 8, D-91074 Herzogenaurach, Germany Phone: +49 (0) 9132 777-0 Fax: +49 (0) 9132 777-150 E-Mail: info@proleit.com Internet: http://www.proleit.com

More information

Organization Profile. IT Services

Organization Profile. IT Services Introduction In today s scientific and medical world, various issues in clinical trials and research have permeated every society and every field in medicine. Ethics and in particular the quality of research

More information

Overview. Disasters are happening more frequently and Recovery is taking on a different perspective.

Overview. Disasters are happening more frequently and Recovery is taking on a different perspective. Overview Disasters are happening more frequently and Recovery is taking on a different perspective. Defining a Disaster/Disaster Recovery Basic requirements in preparing for a disaster The role of Quality

More information

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software

More information

Document Number: SOP/RAD/SEHSCT/007 Page 1 of 17 Version 2.0

Document Number: SOP/RAD/SEHSCT/007 Page 1 of 17 Version 2.0 Standard Operating Procedures (SOPs) Research and Development Office Title of SOP: Computerised Systems for Clinical Trials SOP Number: 7 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013

More information

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL

More information

Considerations When Validating Your Analyst Software Per GAMP 5

Considerations When Validating Your Analyst Software Per GAMP 5 WHITE PAPER Analyst Software Validation Service Considerations When Validating Your Analyst Software Per GAMP 5 Blair C. James, Stacy D. Nelson Introduction The purpose of this white paper is to assist

More information